Licensed indications 2,3 2,3 Subcutaneous semaglutide (Wegovy) and tirzepatide (Mounjaro) are indicated as adjuncts to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial BMI of: 30 kg/m 2 (obesity), or 27 kg/m 2 to 2 days away, administer as soon as possible
FAQs Is it normal to lose only a little in the first month
50mg and 100mg lyophilized vials
How to Store Semaglutide Correctly in Daily Life Best practices recommended by manufacturers and clinical guidelines include: Refrigerating unopened medication Avoiding freezing at all times Keeping opened medication below 86F (30C) Protecting from direct sunlight Monitoring usage duration carefully These recommendations are consistent with guidance from regulatory agencies and clinical pharmacology research
You can inject it in areas such as the abdomen, thigh, or upper arm, with guidance from your provider on proper technique and injection site rotation